Sequential administration of two oncostatic drugs: study of modalities for pharmacodynamic potentiation.
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002330:Carmustine / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D003609:Dactinomycin / Q000008:administration & dosage; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D007700:Kinetics; D007939:Leukemia L1210 / Q000188:drug therapy*; D008130:Lomustine / Q000008:administration & dosage; D008433:Mathematics; D008727:Methotrexate / Q000008:administration & dosage; D051379:Mice; D008937:Mitomycins / Q000008:administration & dosage; D009368:Neoplasm Transplantation; D009607:Nitrosourea Compounds / Q000008:administration & dosage; D013997:Time Factors; D014750:Vincristine / Q000008:administration & dosage
D000970:Antineoplastic Agents; D008937:Mitomycins; D009607:Nitrosourea Compounds; D003561:Cytarabine; D003609:Dactinomycin; D014750:Vincristine; D008130:Lomustine; D003520:Cyclophosphamide; D005472:Fluorouracil; D002330:Carmustine; D008727:Methotrexate